Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update.

Giordano, Sharon H; Franzoi, Maria Alice B; Temin, Sarah; Anders, Carey K; Chandarlapaty, Sarat; Crews, Jennie R; Kirshner, Jeffrey J; Krop, Ian E; Lin, Nancy U; Morikawa, Aki; Patt, Debra A; Perlmutter, Jane; Ramakrishna, Naren; Davidson, Nancy E

Giordano, Sharon H; Franzoi, Maria Alice B; Temin, Sarah; Anders, Carey K; Chandarlapaty, Sarat; Crews, Jennie R; Kirshner, Jeffrey J; Krop, Ian E; Lin, Nancy U; Morikawa, Aki; Patt, Debra A; Perlmutter, Jane; Ramakrishna, Naren; Davidson, Nancy E.

Affiliation

Giordano SH; University of Texas MD Anderson, Houston, TX.
Franzoi MAB; Institute Gustave Roussy, Villejuif, France.
Temin S; American Society of Clinical Oncology, Alexandria, VA.
Anders CK; Duke University, Durham, NC.
Chandarlapaty S; Memorial Sloan Kettering Cancer Center, New York, NY.
Crews JR; Seattle Cancer Care Alliance, Seattle, WA.
Kirshner JJ; Hematology/Oncology Associates of Central New York, East Syracuse, NY.
Krop IE; Dana-Farber Cancer Institute, Boston, MA.
Lin NU; Dana-Farber Cancer Institute, Boston, MA.
Morikawa A; University of Michigan, Ann Arbor, MI.
Patt DA; Texas Oncology, Austin, TX.
Perlmutter J; Patient Advocate, Ann Arbor, MI.
Ramakrishna N; University of Florida Health Cancer Center at Orlando Health, Orlando, FL.
Davidson NE; Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA.

J Clin Oncol ; 40(23): 2612-2635, 2022 08 10.

Article de En | MEDLINE | ID: mdl-35640077

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein Type d'étude: Guideline / Prognostic_studies / Systematic_reviews Limites: Female / Humans Langue: En Journal: J Clin Oncol Année: 2022 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google